Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes



Rating:

Share or cite this content

Citations should be made in the following way:
M. Bottier (Dundee, United Kingdom), E. Cant (Dundee, United Kingdom), L. Delgado (Dundee, United Kingdom), D. Cassidy (Dundee, United Kingdom), Y. Giam (Dundee, United Kingdom), A. Smith (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), J. Huang (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), L. Perea (Barcelona, Spain), S. Finch (Dundee, United Kingdom), S. Aliberti (Monza, Italy), O. Sibila (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom). Mapping inflammatory endotypes of bronchiectasis associated with impaired mucociliary clearance. 1311

Member's Comments

No comment yet.

Related content which might interest you: IPF: a genetic disease that involves mucociliary dysfunction of the peripheral airways Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research Year: 2016 Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect Source: Eur Respir J 2004; 24: 95-100 Year: 2004 Pharmacological airway clearance strategies in bronchiectasis Source: Eur Respir Mon 2011; 52: 239-247 Year: 2011 Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms Source: Eur Respir J 2008; 31: 396-406 Year: 2008 Dynamic hyperinflation contributes to systemic and airway inflammation in patients with COPD Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019 EXACT-PRO correlates with FEV1 and systemic inflammation but not airway inflammation Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 May impairment of mucociliary clearance in COPD be reversible? Source: Annual Congress 2013 –COPD and tobacco management Year: 2013 Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017 Year: 2018 Airway inflammation in COPD: physiological outcome measures and induced sputum Source: Eur Respir J 2003; 21: 19S-28S Year: 2003 Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014 The association between bronchiectasis and systemic inflammation Source: International Congress 2019 – Bronchiectasis Year: 2019 Parameters associated with persistent airflow obstruction in chronic severe asthma Source: Eur Respir J 2004; 24: 122-128 Year: 2004 COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Source: Eur Respir J 2012; 39: 830-838 Year: 2012 Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003 Presence of progranulin in airway inflammation associated with COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Impaired lung function is associated with systemic inflammation and macrophage activation Source: Eur Respir J 2015; 45: 557-559 Year: 2015 Systemic and airway inflammation and the presence of emphysema in patients with COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Mucociliary clearance in patients with chronic bronchitis Source: Eur Respir J 2005; 26: Suppl. 49, 302s Year: 2005 Airways' remodelling contributes to abnormal lung function and bronchial hyperresponsiveness during clinical remission of atopic asthma Source: Eur Respir J 2001; 18: Suppl. 33, 4s Year: 2001